gms | German Medical Science

information platform

Germany, Land of Ideas

Deutsche Initiative für Netzwerkinformation (DINI, German Initiative for Network Information)

Your initial contact to the requested addressee


Here you can get in touch with the recipient specified below.

All indicated mandatory fields () have to be completed.
Using this functionality for commercial advertising is prohibited.

Recipient: Karsten Neuber
Article: Clinical phase I/II trial to assess antitumor activity and tolerability of dacarbazine i.v. plus Imatinib (Glivec) orally in patients with metastatic malignant melanoma
27. Deutscher Krebskongress. Berlin, 22.-26.03.2006. Düsseldorf, Köln: German Medical Science; 2006. DocPO613 (PO613)